This afternoon, well afternoon here in Berlin anyway, Abbott announced the FreeStyle Libre 2 has earned a CE Mark. Per a press release;
“People living with diabetes in Europe will now have the choice to be alerted in real-time of hypoglycemia (low glucose levels1) or hyperglycemia (high glucose levels1) through the FreeStyle® Libre 2 system, a continuous glucose monitoring system (CGM). Abbott (NYSE: ABT) today announced that it has secured CE Mark (Conformité Européenne) for its FreeStyle Libre 2 system—the next generation of FreeStyle Libre, which safely and successfully replaces self-monitoring of blood glucose without the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.